Clover Bio­phar­ma­ceu­ti­cals sets up a new R&D cen­ter in a buzzy Chi­nese hub near Shang­hai

Busi­ness in Chi­na is boom­ing, with more than a thou­sand biotech and bio­phar­ma com­pa­nies — in­clud­ing some big multi­na­tion­al play­ers — flock­ing to Zhangjiang Phar­ma Val­ley to take ad­van­tage of a grow­ing tal­ent pool in Shang­hai.

Clover Bio­phar­ma­ceu­ti­cals is the lat­est, an­nounc­ing on Wednes­day that it has be­gun con­struc­tion on a new R&D cen­ter in Zhangjiang Hi-Tech Park. The Chi­nese biotech (which al­so has a cor­po­rate of­fice in Boston) promis­es a state-of-the-art fa­cil­i­ty with new pre­clin­i­cal re­search labs, man­u­fac­tur­ing process de­vel­op­ment labs, and a GMP pi­lot man­u­fac­tur­ing plant.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER